Kevin DAmour - Chief Scientific Officer at Eterna Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Scientific Officer
Stock Symbol
ERNA on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kevin DAmour since 9/17/2023

Holdings reported by Kevin DAmour for Eterna Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 52.7K $131K $2.48 Jun 28, 2022 Direct Common Stock
Common Stock 11.5K $28.5K $2.48 Jun 28, 2022 Direct

Transactions reported by Kevin DAmour for Eterna Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.